Storia in 1 fonti

Dr Reddy's to expand biosimilars, oncology and innovation-led businesses

Dr Reddy's plans to drive growth through biosimilars, peptides, oncology, consumer healthcare and innovation while strengthening its core generics and API businesses.

Raccontata da

thehindubusinessline.com

Timeline cronologica

giovedì 16 luglio 2026·thehindubusinessline.com
Dr Reddy's to expand biosimilars, oncology and innovation-led businesses
Dr Reddy's plans to drive growth through biosimilars, peptides, oncology, consumer healthcare and innovation while strengthening its core generics and API businesses.